Quick Answer
REGENEREX PHARMA, INC. reported Total Revenue of $1.8 thousand for fiscal year 2021.
REGENEREX PHARMA, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2021 | $1.8K | -31.9% |
| 2020 | $2.6K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| December 31, 2020 | $181.00 | -89.2% | +50.8% |
| September 30, 2020 | $120.00 | — | +55.8% |
| June 30, 2020 | $77.00 | — | -95.4% |
| December 31, 2019 | $1.7K | — | -81.9% |
| August 31, 2014 | $9.2K | — | — |
- REGENEREX PHARMA, INC. showed a decrease of -31.9% in Total Revenue compared to the prior fiscal year.
- Over the 2020–2021 period, REGENEREX PHARMA, INC.’s total revenue has declined by 31.9% (from $2.6 thousand to $1.8 thousand).
- The most recent figure is from REGENEREX PHARMA, INC.’s fiscal year 2020 report (Form 10-K), filed with the SEC on June 23, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: